HUP0105132A3 - Process for preparing imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones and the use of the same for preparing pharmaceutical compositions - Google Patents
Process for preparing imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones and the use of the same for preparing pharmaceutical compositionsInfo
- Publication number
- HUP0105132A3 HUP0105132A3 HU0105132A HUP0105132A HUP0105132A3 HU P0105132 A3 HUP0105132 A3 HU P0105132A3 HU 0105132 A HU0105132 A HU 0105132A HU P0105132 A HUP0105132 A HU P0105132A HU P0105132 A3 HUP0105132 A3 HU P0105132A3
- Authority
- HU
- Hungary
- Prior art keywords
- preparing
- pyrazinones
- pyrido
- pharmaceutical compositions
- same
- Prior art date
Links
- NAXIXAPHUQGPPU-UHFFFAOYSA-N N1=CC2=CN=CN2C2=C1C=CC(=O)N2 Chemical class N1=CC2=CN=CN2C2=C1C=CC(=O)N2 NAXIXAPHUQGPPU-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1999102082 DE19902082A1 (de) | 1999-01-20 | 1999-01-20 | Verwendung von Imidazo[1,5-a]-pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erectiler Dysfunktion und Verfahren zu deren Herstellung |
DE1999161302 DE19961302A1 (de) | 1999-12-18 | 1999-12-18 | Verwendung von Imidazo(1,5-a)-pyrido(3,2-e)-pyrazinonen als duale Inhibitoren der Phosphodiesterase 5 und der Phosphodiesterase 3 zur Therapie der Herzinsuffizienz, von pulmonaler Hypertonie und Gefäßerkrankungen, die mit einer Minderdurchblutung einhergehen |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0105132A2 HUP0105132A2 (hu) | 2002-05-29 |
HUP0105132A3 true HUP0105132A3 (en) | 2002-12-28 |
Family
ID=26051406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0105132A HUP0105132A3 (en) | 1999-01-20 | 2000-01-14 | Process for preparing imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones and the use of the same for preparing pharmaceutical compositions |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1144410A2 (zh) |
JP (1) | JP2002535330A (zh) |
KR (1) | KR20010101603A (zh) |
CN (1) | CN1344268A (zh) |
AR (1) | AR022318A1 (zh) |
AU (1) | AU2291200A (zh) |
BG (1) | BG105714A (zh) |
BR (1) | BR0007613A (zh) |
CA (1) | CA2296224A1 (zh) |
CO (1) | CO5190700A1 (zh) |
CZ (1) | CZ20012627A3 (zh) |
EA (1) | EA200100792A1 (zh) |
EE (1) | EE200100377A (zh) |
HU (1) | HUP0105132A3 (zh) |
ID (1) | ID29790A (zh) |
IL (1) | IL144156A0 (zh) |
IS (1) | IS5987A (zh) |
LT (1) | LT2001078A (zh) |
LV (1) | LV12793B (zh) |
NO (1) | NO20013334D0 (zh) |
SK (1) | SK10322001A3 (zh) |
TR (1) | TR200102121T2 (zh) |
WO (1) | WO2000043392A2 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403597B1 (en) | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
US6548490B1 (en) | 1997-10-28 | 2003-04-15 | Vivus, Inc. | Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
WO2003051346A2 (en) * | 2001-12-17 | 2003-06-26 | Altana Pharma Ag | Use of selective pde5 inhibitors for treating partial and global respiratory failure |
US6916345B2 (en) | 2002-02-12 | 2005-07-12 | L'oreal S.A. | 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres |
FR2835741B1 (fr) * | 2002-02-12 | 2006-05-05 | Oreal | Nouveaux coupleurs 6-alcoxy-2,3-diaminopyridine utiles pour la teinture des fibres keratiniques |
DE10325813B4 (de) | 2003-06-06 | 2007-12-20 | Universitätsklinikum Freiburg | Prophylaxe und/oder Therapie bei der portalen Hypertonie |
JP5070052B2 (ja) | 2004-08-17 | 2012-11-07 | ザ・ジョンズ・ホプキンス・ユニバーシティ | Pde5阻害剤組成物及び心臓疾患を治療する方法 |
ES2536906T3 (es) | 2006-12-13 | 2015-05-29 | Aska Pharmaceutical Co., Ltd. | Derivado de quinoxalina |
US20090143361A1 (en) * | 2007-11-30 | 2009-06-04 | Elbion Gmbh | Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 |
CN101918408A (zh) | 2007-11-30 | 2010-12-15 | 惠氏有限责任公司 | 作为磷酸二酯酶10的抑制剂的芳基和杂芳基稠合的咪唑并[1,5-a]吡嗪 |
JP2015531401A (ja) | 2011-10-10 | 2015-11-02 | ハー・ルンドベック・アクチエゼルスカベット | イミダゾピラジノン骨格を有するpde9i |
CN107082783B (zh) | 2012-01-26 | 2019-03-22 | H.隆德贝克有限公司 | 具有咪唑并三嗪酮骨架的pde9抑制剂 |
JP5842640B2 (ja) * | 2012-01-31 | 2016-01-13 | 株式会社東洋新薬 | ホスホジエステラーゼ3阻害剤 |
US10005789B2 (en) | 2014-08-07 | 2018-06-26 | Intra-Cellular Therapies, Inc. | Organic compounds |
WO2016022825A1 (en) * | 2014-08-07 | 2016-02-11 | Intra-Cellular Therapies, Inc. | Organic compounds |
PL3865484T3 (pl) | 2015-07-07 | 2024-04-22 | H. Lundbeck A/S | Inhibitor PDE9 ze szkieletem imidazopirazynonowym do leczenia chorób obwodowych |
KR20210014662A (ko) | 2018-05-25 | 2021-02-09 | 이마라 인크. | 6-[(3S,4S)-4-메틸-1-(피리미딘-2-일메틸)피롤리딘-3-일]-3-테트라히드로피란-4-일-7H-이미다조[1,5-a]피라진-8-온의 일수화물 및 결정형 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5055465A (en) * | 1989-05-31 | 1991-10-08 | Berlex Laboratories, Inc. | Imidazoquinoxalinones, their aza analogs and process for their preparation |
DE19510965A1 (de) * | 1995-03-24 | 1996-09-26 | Asta Medica Ag | Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung |
-
2000
- 2000-01-14 KR KR1020017009112A patent/KR20010101603A/ko not_active Application Discontinuation
- 2000-01-14 CZ CZ20012627A patent/CZ20012627A3/cs unknown
- 2000-01-14 CN CN00805307A patent/CN1344268A/zh active Pending
- 2000-01-14 WO PCT/EP2000/000260 patent/WO2000043392A2/de not_active Application Discontinuation
- 2000-01-14 SK SK1032-2001A patent/SK10322001A3/sk unknown
- 2000-01-14 TR TR2001/02121T patent/TR200102121T2/xx unknown
- 2000-01-14 EA EA200100792A patent/EA200100792A1/ru unknown
- 2000-01-14 EP EP00901561A patent/EP1144410A2/de not_active Withdrawn
- 2000-01-14 ID IDW00200101592A patent/ID29790A/id unknown
- 2000-01-14 JP JP2000594808A patent/JP2002535330A/ja active Pending
- 2000-01-14 IL IL14415600A patent/IL144156A0/xx unknown
- 2000-01-14 BR BR0007613-9A patent/BR0007613A/pt not_active Application Discontinuation
- 2000-01-14 AU AU22912/00A patent/AU2291200A/en not_active Abandoned
- 2000-01-14 EE EEP200100377A patent/EE200100377A/xx unknown
- 2000-01-14 HU HU0105132A patent/HUP0105132A3/hu unknown
- 2000-01-19 CA CA002296224A patent/CA2296224A1/en not_active Abandoned
- 2000-01-19 CO CO00002747A patent/CO5190700A1/es not_active Application Discontinuation
- 2000-01-19 AR ARP000100246A patent/AR022318A1/es unknown
-
2001
- 2001-06-29 IS IS5987A patent/IS5987A/is unknown
- 2001-07-05 NO NO20013334A patent/NO20013334D0/no not_active Application Discontinuation
- 2001-07-17 BG BG105714A patent/BG105714A/xx unknown
- 2001-07-19 LV LV010109A patent/LV12793B/lv unknown
- 2001-07-19 LT LT2001078A patent/LT2001078A/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR022318A1 (es) | 2002-09-04 |
IS5987A (is) | 2001-06-29 |
CZ20012627A3 (cs) | 2002-01-16 |
BG105714A (en) | 2002-02-28 |
ID29790A (id) | 2001-10-11 |
HUP0105132A2 (hu) | 2002-05-29 |
WO2000043392A2 (de) | 2000-07-27 |
NO20013334L (no) | 2001-07-05 |
NO20013334D0 (no) | 2001-07-05 |
LV12793A (lv) | 2002-02-20 |
CO5190700A1 (es) | 2002-08-29 |
EA200100792A1 (ru) | 2002-10-31 |
LV12793B (lv) | 2002-05-20 |
IL144156A0 (en) | 2002-05-23 |
LT2001078A (en) | 2002-08-26 |
EE200100377A (et) | 2002-10-15 |
SK10322001A3 (sk) | 2002-07-02 |
TR200102121T2 (tr) | 2002-01-21 |
CN1344268A (zh) | 2002-04-10 |
KR20010101603A (ko) | 2001-11-14 |
EP1144410A2 (de) | 2001-10-17 |
AU2291200A (en) | 2000-08-07 |
JP2002535330A (ja) | 2002-10-22 |
CA2296224A1 (en) | 2000-07-20 |
BR0007613A (pt) | 2001-10-30 |
WO2000043392A3 (de) | 2000-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0202494A2 (en) | Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0200450A3 (en) | Cephen derivatives containing an imidazo[4,5-b]pyridiniummethyl moiety, process for their preparation and pharmaceutical compositions of the same | |
HUP0105081A3 (en) | Triazolo[4,5-d]pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0203450A3 (en) | Pyrazolo '4,3-d! pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use | |
HUP0100202A3 (en) | Novel triazolo[4,5-d]pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0203142A3 (en) | Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
HUP0203503A3 (en) | Pyrrolo[2,3-d]pirimidine compounds, pharmaceutical compositions containing them and their use | |
IL128869A (en) | ARYSULFONYL-SUBSTITUTED-PYRAZOLO [1,5-a]-PYRIMIDINE AND PYRAZOLO [1,5-a] [1, 3, 5]-TRIAZINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
HUP0204246A3 (en) | Novel thiazolo[4,5-d]pyrimidine compounds, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0004708A3 (en) | 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0200207A3 (en) | Substituted 2-aryl-3-(hetroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compositions and methods for their preparation | |
HUP0202103A2 (en) | 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives, their use, pharmaceutical compositions containing them, process for the preparation of the compounds and intermediates | |
HUP0004333A3 (en) | Novel triazolo [4,5-d] pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing thereof | |
HUP0001507A3 (en) | Pyrrolo [2,3-d] pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0203545A3 (en) | Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives, pharmaceutical compositions containing them, process for their preparation and their use | |
HUP0401292A3 (en) | Pyrazolo[1,5-a]pyridines, pharmaceutical compositions containing the same and process for preparation thereof | |
HUP0303350A3 (en) | Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting pharmaceutical compositions | |
HUP0203052A3 (en) | Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0202100A3 (en) | Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same | |
HUP0105132A3 (en) | Process for preparing imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones and the use of the same for preparing pharmaceutical compositions | |
HUP0000720A3 (en) | Imidazo [1,2-a] pyridine derivatives, process for their preparation, pharmaceutical formulation containing them and their use | |
HUP0002480A3 (en) | Pyrrolo[2,1-c][1,4]benzodiazepine derivatives, their use, process for their preparation and pharmaceutical compositions containing them | |
HUP0003826A3 (en) | Novel triazolo [4,5-b] pyrimidine derivatives, process for their preparation and pharmaceutical compositions thereof | |
HUP0202624A3 (en) | Pyrazolo[4,3-d]pyrimidine-derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0104164A3 (en) | Imidazo[4,5-c]-pyridine-4-one derivatives with factor xa inhibiting effect, pharmaceutical compositions containing the same and process for their preparation |